Island Pharmaceuticals Ltd (ila) Logo

Island Pharmaceuticals Ltd (ILA)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
06/2021
06/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Profitability
NPAT ($) (2,126,755) - - - - - - - - -
NPAT Margin -- -- - - - - - - - -
Return on Equity (ROE) -33.24% 0.00% - - - - - - - -
Return on Assets (ROA) -32.05% 0.00% - - - - - - - -
Valuation
PE Ratio (2.45) 0.00 - - - - - - - -
PE Relative to Market 0.0% -- - - - - - - - -
Price to Book 3.54 0.00 - - - - - - - -
Price to Cash Flow (15.23) 0.00 - - - - - - - -
Shares Outstanding (M) 80.97 80.97 - - - - - - - -
Market Cap ($M) $22.67 $0.00 - - - - - - - -
Enterprise Value ($M) $16.21 $-7.50 - - - - - - - -
Performance
Total Shareholder Return 0.0% -- - - - - - - - -
Relative to Market 0.0% -- - - - - - - - -
Per Share
Earnings (11.41) 0.00 - - - - - - - -
Cash Flow (5.00) 0.00 - - - - - - - -
Cash 0.08 0.09 - - - - - - - -
Net Tangible Assets 0.08 0.09 - - - - - - - -
Book Value 0.08 0.09 - - - - - - - -
Share Price $0.28 $0.00 - - - - - - - -
Liquidity
Quick Ratio 28.02 51.03 - - - - - - - -
Current Ratio 28.02 51.03 - - - - - - - -
Efficiency
Asset Turnover 0.00 0.00 - - - - - - - -
Inventory Turnover - - - - - - - - - -
Working Capital Turnover 0.00 0.00 - - - - - - - -
Dividends
DPS (c) - - - - - - - - - -
Dividend yield - - - - - - - - - -
Franking - - - - - - - - - -
Gross DPS (c) - - - - - - - - - -
Gross Dividend Yield - - - - - - - - - -
Payout Ratio - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2021
06/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
INCOME
Trading Revenue - - - - - - - - - -
Other Income - - - - - - - - - -
Total Income Excl. Interest - - - - - - - - - -
INTEREST/FINANCE INCOME
Forex Gain/Loss - - - - - - - - - -
Total Income - - - - - - - - - -
EXPENSES
Expenses (2,126,755) - - - - - - - - -
EBITDA (2,126,755) - - - - - - - - -
DEPRECIATION AND AMORTISATION
Depreciation - - - - - - - - - -
Amortisation - - - - - - - - - -
Depreciation & Amortisation - - - - - - - - - -
EBIT (2,126,755) - - - - - - - - -
INTEREST/FINANCE EXPENSES
Interest/Finance Income - - - - - - - - - -
Interest Expense - - - - - - - - - -
Interest Capitalised - - - - - - - - - -
Interest Expenses Incl. Capital - - - - - - - - - -
Net Interest Expenses - - - - - - - - - -
Pre-Tax Profit (2,126,755) - - - - - - - - -
Net Capital Profits - - - - - - - - - -
Pre-Tax Profit Pre-Cap (2,126,755) - - - - - - - - -
TAX
Tax Expenses - - - - - - - - - -
NPAT before Abnormals (2,126,755) - - - - - - - - -
ABNORMALS
Abnormals - - - - - - - - - -
Abnormals Tax - - - - - - - - - -
Net Abnormals - - - - - - - - - -
Non-Controlling Interests - - - - - - - - - -
Reported NPAT after Abnormals (2,126,755) - - - - - - - - -
NPAT before Capital (2,126,755) - - - - - - - - -
EQUITY
Diluted Shares 80,968,468 80,968,468 - - - - - - - -
Diluted Weighted Shares 18,633,840 80,968,468 - - - - - - - -
Ordinary Dividends - - - - - - - - - -
Preference Dividends - - - - - - - - - -
EPS Adjusted (114,100) - - - - - - - - -
EPS after Abnormals (114,134) - - - - - - - - -
Share of net Profit/Loss - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2021
06/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Assets
Cash 6,460,644 7,502,000 - - - - - - - -
Receivables 59,147 - - - - - - - - -
Prepayments 116,119 - - - - - - - - -
Inventories - - - - - - - - - -
Investments - - - - - - - - - -
Other - - - - - - - - - -
Total Current Assets 6,635,910 7,502,000 - - - - - - - -
Non-current assets
Receivables - - - - - - - - - -
Inventories - - - - - - - - - -
PP&E - - - - - - - - - -
Investments - - - - - - - - - -
Intangibles Excl. Goodwill - - - - - - - - - -
Goodwill - - - - - - - - - -
Future Income Tax Benefit - - - - - - - - - -
Other - - - - - - - - - -
Total Non-Current Assets - - - - - - - - - -
Total Assets 6,635,910 7,502,000 - - - - - - - -
Current Liabilities
Accounts Payable 230,483 1,000 - - - - - - - -
Provisions 6,347 - - - - - - - - -
Short Term Debt - - - - - - - - - -
Other - 146,000 - - - - - - - -
Total Current Liabilities 236,830 147,000 - - - - - - - -
Non-current liabilities
Accounts Payable - - - - - - - - - -
Long Term Debt - - - - - - - - - -
Provisions - - - - - - - - - -
Other - - - - - - - - - -
Total Non-Current Liabilities - - - - - - - - - -
Total Liabilities 236,830 147,000 - - - - - - - -
Shareholder Equity
Share Capital 19,825,792 22,374,000 - - - - - - - -
Convertible Equity - - - - - - - - - -
Other Equity - - - - - - - - - -
Reserves ex. Share Premium (11,299,298) (2,231,000) - - - - - - - -
Share Premium Reserves - - - - - - - - - -
Retained Profits (2,127,414) (12,788,000) - - - - - - - -
Total Available Equity Assets 6,400,000 - - - - - - - - -
External Equity
Non-controlling Interests - - - - - - - - - -
Net Assets 6,399,080 7,355,000 - - - - - - - -
Total Debt - - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo
06/2021
06/2020
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
OPERATING ACTIVITIES
Receipts - - - - - - - - - -
Payments (938,236) - - - - - - - - -
Dividends Received - - - - - - - - - -
Interest Received - - - - - - - - - -
Interest Paid - - - - - - - - - -
Taxes Paid - - - - - - - - - -
Other - - - - - - - - - -
Net Operating Cash Flow (938,236) - - - - - - - - -
INVESTMENT ACTIVITIES
Capital Expend. Excl. Investments - - - - - - - - - -
Payments for Investment - - - - - - - - - -
Payments for Subsidiaries - - - - - - - - - -
Proceeds from PP&E - - - - - - - - - -
Proceeds from Investments - - - - - - - - - -
Proceeds from Subsidiaries 77,371 - - - - - - - - -
Loans Granted - - - - - - - - - -
Loans Repaid - - - - - - - - - -
Other Investments - - - - - - - - - -
Net Investment Cash Flow 77,371 - - - - - - - - -
Operating CF less Investment CF (860,865) - - - - - - - - -
FINANCING ACTIVITIES
Proceeds from Issues 7,500,000 - - - - - - - - -
Proceeds from Borrowings - - - - - - - - - -
Repayment of Borrowings - - - - - - - - - -
Dividends Paid - - - - - - - - - -
Other Financing Activities (201,971) - - - - - - - - -
Net Financing Cash Flow 7,298,029 - - - - - - - - -
Total Net Cashflow 6,437,164 - - - - - - - - -
CASH
Cash and Cash Equiv. Period Open 1 - - - - - - - - -
Exchange Rate Adjustments 23,479 - - - - - - - - -
Other Cash Adjustments - - - - - - - - - -
Cash and Cash Equiv. Period Close 6,460,644 - - - - - - - - -
Membership required
Member Content
Source:
Morningstar Logo